Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| US BioTec Inc New Common Shares (NASDAQ: SBC) | Delayed: 5.69 +0.15 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $0.40 | |||
| Open | $5.50 | 52 Week Low | $0.40 | |||
| Day High | $5.72 | P/E | N/A | |||
| Day Low | $5.46 | EPS | $0.00 | |||
| Volume | 221,391 | |||||
